iKang Healthcare Group, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2018 12 months to Mar 31, 2018	FY2017 12 months to Mar 31, 2017	FY2016 12 months to Mar 31, 2016	FY2015 12 months to Mar 31, 2015	FY2014 12 months to Mar 31, 2014
Net revenues
Cost of revenues
Gross profit
Operating expenses:
Selling and marketing expenses
General and administrative expenses (including share-based compensation expenses of $1,949, $1,941 and $34,822 in 2016, 2017 and 2018, respectively)
Research and development expenses
Total operating expenses
Impairment of goodwill
Income from operations
Loss from forward contracts
Interest expense
Interest income
Income before provision for income taxes and loss from equity method investment
Other income
Income/(loss)before provision for income taxes and gain/(loss) from equity method investments
Loss from equity method investment
Income tax expenses
Income/(loss) before loss from equity method investments
Loss from equity method investments
Net income/(loss)
Less: Net income/(loss) attributable to non-controlling interest
Net income/(loss) attributable to iKang Healthcare Group, Inc.
Deemed dividend to preferred shareholders
Undistributed earnings allocated to preferred shareholders
Net income/(loss) attributable to common shareholders of iKang Healthcare Group, Inc.
Net income/(loss) per share attributable to common shareholders of iKang Healthcare Group, Inc.
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average shares used in calculating net (loss) income per common share
Basic (in shares)
Diluted (in shares)

Comments